NEW YORK, Sept. 30, 2026 /PRNewswire/ -- Consolidated Edison, Inc. (NYSE: ED) will webcast the company's Annual Investor Relations Update from 8:30 a.m.

Concentra is executing a compelling operational turnaround, evidenced by accelerating revenue growth of 10.0% YoY in Q2 2026 and a 630 basis point gross margin expansion to 31.7% over two years. Operating leverage is driving profitability, with operating incom...
Price trend, volume and key moving averages
Trailing total returns as of 10/7/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 6, 2026 | $0.52+23.3% vs $0.42 | $606M+2.4% vs $592M |
Q2 2026 May 7, 2026 | $0.40+14.3% vs $0.35 | $570M+2.9% vs $554M |
Q1 2026 Jan 28, 2026 | $0.28+23.5% vs $0.23 | $539M+1.3% vs $532M |
Q4 2025 Nov 6, 2025 | $0.39+5.4% vs $0.37 | $573M+7.7% vs $532M |
NEW YORK, Sept. 30, 2026 /PRNewswire/ -- Consolidated Edison, Inc. (NYSE: ED) will webcast the company's Annual Investor Relations Update from 8:30 a.m.

Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
NEW YORK , Sept. 16, 2026 /PRNewswire/ -- Consolidated Edison, Inc. (NYSE: ED) will webcast an investor presentation from 8:30 a.m.
Concentra Group Holdings Parent, rated BUY, has surged 78% YTD, driven by market share gains and strong operating leverage. CON beat 2Q26 earnings estimates, with revenue up 10% YoY and adjusted EBITDA up 22.5%, aided by higher patient revenue per visit. Future growth may be propelled by additional state-level workers' compensation reimbursement increases and a robust M&A pipeline.
Benchmark CON against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Concentra Group Holdings Parent, Inc. (CON)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $36.40 | $4.66B | 28.00 | 13.85% | 7.99% | 48.06% | 0.69% | |
| $23.60 | $441.41M | 9.55 | 2.63% | 14% | 18.37% | — | |
| $44.77 | $13.33B | 23.08 | 13.95% | 66.43% | 15.76% | — | |
| $29.04 | $2.7B | -2.39 | 5.04% | -33.44% | -46.01% | — | |
| $16.51 | $2.05B | 13.99 | 5.12% | 2.42% | 6.55% | — | |
| $83.63 | $1.27B | 58.89 | 16.33% | 0.32% | 0.29% | — |
Concentra Group Holdings Parent, Inc. (CON) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Concentra Group Holdings Parent, Inc. (CON) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 6, 2026·SEC
Jul 10, 2026·SEC
May 7, 2026·SEC
Get notified when CON posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Concentra Group Holdings Parent, Inc. (CON) stock FAQ — growth, dividends, profitability & financials explained
Concentra Group Holdings Parent, Inc. (CON) reported $2.29B in revenue for fiscal year 2025. This represents a 33% increase from $1.72B in 2022.
Concentra Group Holdings Parent, Inc. (CON) grew revenue by 13.9% over the past year. This is steady growth.
Yes, Concentra Group Holdings Parent, Inc. (CON) is profitable, generating $198.7M in net income for fiscal year 2025 (8.0% net margin).
Yes, Concentra Group Holdings Parent, Inc. (CON) pays a dividend with a yield of 0.69%. This makes it attractive for income-focused investors.
Concentra Group Holdings Parent, Inc. (CON) has a return on equity (ROE) of 48.1%. This is excellent, indicating efficient use of shareholder capital.
Concentra Group Holdings Parent, Inc. (CON) generated $349.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.